Disease Markers
Volume 2019 (2019), Article ID 1045098, 9 pages
https://doi.org/10.1155/2019/1045098

Research Article

Bone Mineral Density as a Predictor of Atherogenic Indexes of Cardiovascular Disease, Especially in Nonobese Adults

Tzyy-Ling Chuang,1,2 Jiunn-Wen Lin,³ and Yuh-Feng Wang1,2

¹Department of Nuclear Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan
²School of Medicine, Tzu Chi University, Hualien, Taiwan
³Department of Cardiology, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan

Correspondence should be addressed to Yuh-Feng Wang; yuhfeng@gmail.com

Received 13 February 2019; Revised 10 May 2019; Accepted 27 June 2019; Published 4 September 2019

Guest Editor: Agata Bielecka-Dabrowa

Copyright © 2019 Tzyy-Ling Chuang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Purpose. This study is aimed at determining whether bone mineral density (BMD) values are related to atherogenic indexes (AIs) and could predict the risk of cardiovascular disease (CVD) in southern Taiwanese adults. Methods. Medical records of 3249 adults who underwent health examinations between June 2014 and February 2018 at a regional hospital in southern Taiwan were reviewed. Data collected included health history, anthropomorphic characteristics, exercise habits, diets (vegetarian or nonvegetarian), clinical laboratory results (lipid profile, systemic blood pressure (SBP), glucose level, creatinine (Cre) level, and hemoglobin (Hb) level), and bone mineral density (BMD), which were used to identify the associations of these parameters, especially BMD, with lipid profile and calculated AIs through simple and multiple linear regressions. Results. The mean age of the patients was 58.0 years, and 71.4% were male. Body mass index (BMI), SBP, glucose level, Cre level, Hb level, and all BMD values were positively correlated with triglyceride (TG) level and AIs and were negatively correlated with high-density lipoprotein cholesterol (HDL-C) level. The significant positive correlations of BMD at all the measured sites with AIs remained after adjusting for age, sex, SBP, glucose level, Cre level, Hb level, smoking, exercise habits, and vegetarian state. The expanded adjusting model for TG/HDL-C remained significant at all the BMD measured sites in nonobese men, at bilateral femoral neck and total hips in nonobese women, and at the bilateral total hips in obese women. Conclusions. AIs are predictive markers for CVD, and BMD values are predictors of AIs, especially the novel AI, i.e., TG/HDL-C ratio, in nonobese adult men and women after dividing the patients into subgroups to eliminate the effect of BMI as a confounding factor. Thus, BMD values could predict AIs of CVD, especially in nonobese adults.

1. Introduction

Family history, age, smoking, hypertension, diabetes mellitus, low physical activity, and obesity are risk factors for coronary artery disease (CAD) [1]. Traditional lipid profile includes triglyceride (TG), total cholesterol (TCH), and low-density lipoprotein cholesterol (LDL-C), which are all atherogenic, and high-density lipoprotein cholesterol (HDL-C), which is cardioprotective [2–4]. Atherogenic indexes (AIs) are ratios that have atherogenic particles in the numerator and HDL-C in the denominator [5]. The ratios of TCH/HDL-C, LDL-C/HDL-C, and TG/HDL-C (a recent most novel index) could be predictors of CAD risk and extent [1, 5, 6]. Moreover, TCH/HDL-C and LDL-C/HDL-C ratios are useful and simple indexes of ischemic heart disease and cardiovascular disease (CVD) [1, 7, 8]. TG/HDL-C value is found to be a good marker for cardiometabolic risk ratio, and Log(TG/HDL-C) may be a strong marker for predicting the risk of CAD [8, 9].

Previous studies suggested that atherosclerosis and osteoporosis are linked by common risk factors and pathomechanisms [10–12]. Atherosclerosis could include calcified, noncalcified, or mixed lesions. Our previous study suggested that bone microarchitecture remodeling becomes more active when early coronary artery calcification (CAC) occurs [13]. A prediction model based on hypertension, hyperlipidemia, TG, and L-spine -score explained 73.2% of the variance of CAC [14]. Evaluating the correlation between CVD and bone mineral density (BMD) should take their respective factors into consideration. For example, age and menopause act on both in the same direction, whereas body mass index (BMI) acts on them in different directions [15].

The relationship of BMD and lipid profile, especially AIs, remains to be clearly established. HDL-C is reported to be inversely related to BMD [15–17]; however, some studies reported no [18] or positive [19] correlation between HDL-C and BMD. Results of other lipids showed inconsistency [18–23]. A previous study reported that TCH/HDL-C was positively correlated with both femoral neck BMD and total hip BMD [24]. This finding motivated us to conduct this study. Hence, our study is aimed at clarifying the relationship of BMD with AIs and at identifying whether BMD could be an indirect or direct predictor of CVD.

2. Materials and Methods

2.1. Subjects

This retrospective study included adults who underwent health examinations between June 2014 and February 2018 at the preventive medical center of a regional teaching hospital in southern Taiwan. Subjects who previously underwent internal fixation or total hip replacement at sites where BMD was measured were excluded. This study was approved by the ethics committee of our institution, who waived the requirement for informed consent from each patient. Questionnaire records included (1) history of hypertension, diabetes mellitus, and hyperlipidemia; (2) history of smoking and drinking; (3) anthropomorphic characteristics (age, sex, and BMI); (4) exercise habit of greater or equal to 3 times a week; and (5) diet habit of vegetarian or nonvegetarian.

BMI was defined as a person’s weight in kilograms divided by the square of the person’s height in meters (kg/m²). We also divided the population into four subgroups according to sex and obesity status. Classification of nonobese () and obese () subjects was based on the values indicated by the World Health Organization.

2.2. Laboratory Data

The clinical laboratory findings obtained during health examinations included the following: TG, TCH, LDL-C, HDL-C, systolic blood pressure (SBP), glucose level before meal, creatinine (Cre) level, and hemoglobin (Hb) level. The three AIs in this study were TG/HDL-C, TCH/HDL-C, and LDL-C/HDL-C (atherogenic particles in the numerator and HDL-C in the denominator).

2.3. Bone Mineral Density

BMD was assessed by dual-energy X-ray absorptiometry (DXA) using a Discovery Wi DXA system (Hologic Inc.). The areas where BMD was measured included the lumbar spine, the bilateral femoral neck, and the total hip regions. The same densitometer was used for all the patients to ensure accurate comparisons.

2.4. Statistical Analysis

Results were expressed as or number (percentage), as appropriate. Differences in means or frequencies were tested using the chi-square test or -test, as appropriate. Simple linear regression analysis between the parameters and lipid profile and AIs was performed. Simple linear regression between the possible confounding parameters and BMD values was also analyzed. Multiple linear regression analysis was conducted using BMD values of each measured site as the independent variable and AIs as the dependent variables for three models adjusted for the following: (1) age and sex, (2) BMI, and (3) age, sex, SBP, glucose, Cre, Hb, smoking, exercise, and vegetarian. Further, multiple linear regression analysis of the novel AI (i.e., TG/HDL-C) and BMD values was performed for the subgroups after adjusting for age, SBP, glucose level, Cre level, Hb level, smoking, exercise, and vegetarian. All statistical analyses were performed using PASW Statistics 18 suite (SPSS Inc., Chicago, IL).

3. Results

3.1. Subject Characteristics

Medical records of 3249 adults were included. The demographic and clinical characteristics of the subjects are presented in Table 1. The study population was predominantly male (71.4%), with a mean age of years. Analysis of clinical characteristics indicated that 26.9% of the patients had hypertension, 9.6% had diabetes, and 6.9% had hyperlipidemia; moreover, 5.2% were smokers, 42.8% had the habit of exercise, and 42.8% were vegetarians. Significant differences between male and female subjects in smoking, exercise, or diet habits, BMI, SBP, Cre, Hb, TG, TCH, HDL-C, and three calculated AIs were found.

Table 1: Demographic and clinical characteristics of study participants.

All
Male
Female
value

3249
2320
929

Age (range) (years)
(16–90)
(16–90)
(20–88)
0.300

Smoking (%)
169 (5.2)
165 (7.1)
4 (0.4)
<0.001

Hypertension (%)
875 (26.9)
633 (27.3)
242 (26.0)
0.473

Diabetes mellitus (%)
311 (9.6)
229 (9.9)
82 (8.8)
0.361

Hyperlipidemia (%)
225 (6.9)
160 (6.9)
65 (7.0)
0.919

Exercise
1389 (42.8%)
1048 (45.2%)
341 (36.7%)
<0.001

Vegetarian
1392 (42.8%)
863 (37.2%)
529 (56.9%)
<0.001

BMI (kg/m²)

<0.001

SBP (mmHg)

<0.001

Glucose (mg/dL)

0.096

Cre (mg/dL)

<0.001

Hb (g/dL)

<0.001

TG (mg/dL)

<0.001

TCH (mg/dL)

<0.001

LDL-C (mg/dL)

0.052

HDL-C (mg/dL)

<0.001

TG/HDL-C

<0.001

TCH/HDL-C

<0.001

LDL-C/HDL-C

<0.001

L-spine BMD (g/cm²)

<0.001

Right hip neck BMD (g/cm²)

<0.001

Right hip total BMD (g/cm²)

<0.001

Left hip neck BMD (g/cm²)

<0.001

Left hip total BMD (g/cm²)

<0.001

Values in bold represent significant values (). BMI: body mass index; SBP: systolic blood pressure; Cre: creatinine; Hb: hemoglobin; TG: triglyceride; TCH: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol.

3.2. Simple Linear Regression

The lipid profile and AIs were the dependent variables. Age showed significant negative associations with all the lipid profile parameters, except HDL-C level, which showed no correlation. BMI, glucose level, and Hb level showed significant positive correlations with all the lipid profile parameters, except HDL-C level, which showed a negative association. SBP and Cre level were positively correlated with TG level and the three AIs and were inversely correlated with HDL-C level. Male gender and smoking habit were positively correlated with all lipid profile and AIs. Exercise showed negative correlation with atherogenic lipid profile and AIs. Vegetarian diet had negative relationship with TCH, LDL-C, HDL-C, TCH/HDL-C, and LDL-C/HDL-C (Table 2).

Table 2: Simple linear regression for the data analysis: correlation between parameters and lipid profiles and atherogenic indexes by simple regression analysis.

TG
TCH
LDL-C
HDL-C
TG/HDL-C
TCH/HDL-C
LDL-C/HDL-C

Age
-0.066
<0.001
-0.048
0.006
-0.069
<0.001
0.010
0.562
-0.57
0.001
-0.045
0.010
-0.060
0.001

Sex (, )
0.321
<0.001
0.318
<0.001
0.431
<0.001
0.323
<0.001
0.427
<0.001
0.321
<0.001
0.318
<0.001

BMI
0.270
<0.001
0.046
0.008
0.103
<0.001
-0.353
<0.001
0.293
<0.001
0.346
<0.001
0.322
<0.001

SBP
0.088
<0.001
0.026
0.139
0.031
0.077
-0.102
<0.001
0.092
<0.001
0.110
<0.001
0.096
<0.001

Glucose
0.177
<0.001
0.045
0.010
0.036
0.042
-0.135
<0.001
0.171
<0.001
0.150
<0.001
0.116
<0.001

Cre
0.104
<0.001
-0.030
0.082
-0.011
0.540
-0.151
<0.001
0.129
<0.001
0.129
<0.001
0.110
<0.001

Hb
0.182
<0.001
0.122
<0.001
0.171
<0.001
-0.180
<0.001
0.183
<0.001
0.245
<0.001
0.252
<0.001

Smoking
0.076
<0.001
0.115
<0.001
0.081
<0.001
0.110
<0.001
0.073
<0.001
0.076
<0.001
0.115
<0.001

Exercise
-0.070
<0.001
-0.075
<0.001
-0.076
<0.001
0.021
0.222
-0.056
0.001
-0.074
<0.001
-0.076
<0.001

Vegetarian
-0.024
0.167
-0.190
<0.001
-0.169
<0.001
-0.075
<0.001
0.001
0.935
-0.067
<0.001
-0.074
<0.001

L-spine BMD
0.100
<0.001
-0.049
0.005
-0.009
0.623
-0.188
<0.001
0.130
<0.001
0.136
<0.001
0.125
<0.001

Right neck BMD
0.121
<0.001
-0.039
0.026
0.003
0.882
-0.185
<0.001
0.149
<0.001
0.143
<0.001
0.132
<0.001

Right total BMD
0.145
<0.001
-0.037
0.034
-0.003
0.848
-0.215
<0.001
0.164
<0.001
0.163
<0.001
0.142
<0.001

Left neck BMD
0.112
<0.001
-0.029
0.101
0.015
0.407
-0.178
<0.001
0.138
<0.001
0.144
<0.001
0.137
<0.001

Left total BMD
0.144
<0.001
-0.036
0.038
-0.002
0.914
-0.232
<0.001
0.168
<0.001
0.178
<0.001
0.154
<0.001

Values in bold represent significant values (), and values in italic represent negative correlation. BMI: body mass index; SBP: systolic blood pressure; Cre: creatinine; Hb: hemoglobin, TG: triglyceride; TCH: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol.

3.3. Bone Mineral Density

Mean lumbar spine BMD values on DXA were  g/cm² for men,  g/cm² for women, and  g/cm² for all patients. Significant differences in BMD values of the lumbar spine, bilateral femoral neck, and total hip regions between males and females were observed (Table 1).

Moreover, BMD of all the measured sites was significantly positively correlated with TG level and the three AIs and was negatively associated with HDL-C level. All BMD values, except the left femoral neck BMD value, were negatively correlated with TCH level. BMD values at all the sites had no statistically significant relationship with LDL-C levels (Table 2).

For all measured sites, elder age and vegetarian had lower BMDs; moreover, male gender, BMI, Cre, Hb, and smoking had positive effect with BMDs. SBP and glucose showed positive correlation with BMD values of lumbar spine and bilateral total hips. Exercise only had significant positive relationship with the left total hip BMD (Table 3).

Table 3: Simple linear regression for the data analysis: correlation between possible confounding parameters and BMDs by simple regression analysis.

L-spine BMD
Right neck BMD
Right total BMD
Left neck BMD
Left total BMD

Age
-0.118
<0.001
-0.335
<0.001
-0.151
<0.001
-0.328
<0.001
-0.131
<0.001

Sex (, )
0.321
<0.001
0.318
<0.001
0.431
<0.001
0.323
<0.001
0.427
<0.001

BMI
0.327
<0.001
0.336
<0.001
0.380
<0.001
0.343
<0.001
0.395
<0.001

SBP
0.076
<0.001
0.024
0.166
0.134
<0.001
0.026
0.133
0.130
<0.001

Glucose
0.059
0.001
-0.017
0.342
0.037
0.034
-0.004
0.801
0.052
0.003

Cre
0.161
<0.001
0.105
<0.001
0.179
<0.001
0.117
<0.001
0.180
<0.001

Hb
0.183
<0.001
0.248
<0.001
0.303
<0.001
0.252
<0.001
0.291
<0.001

Smoking
0.076
<0.001
0.115
<0.001
0.081
<0.001
0.110
<0.001
0.073
<0.001

Exercise
0.022
0.214
-0.013
0.460
0.021
0.228
-0.013
0.462
0.035
0.043

Vegetarian
-0.164
<0.001
-0.156
<0.001
-0.123
<0.001
-0.170
<0.001
-0.117
<0.001

Values in bold represent significant values (), and values in italic represent negative correlation. BMI: body mass index; SBP: systolic blood pressure; Cre: creatinine; Hb: hemoglobin.

3.4. Multiple Linear Regression

In the analysis of the association of BMD and AIs, multivariate linear regression showed that BMD values at all the regions were positively correlated with AIs in model 1 and model 3 (Table 4). However, in model 2 (adjusted for BMI), all BMD values had a positive correlation with TG/HDL-C ratio but had no relationship with LDL-C/HDL-C ratio. In addition, only the total hip BMD values were positively correlated with TCH/HDL-C ratio (Table 4).

Table 4: Multiple linear regression for the data analysis: correlation between parameters of bone mineral density and atherogenic indexes by multiple regression analysis after adjustment.

TG/HDL-C
TCH/HDL-C
LDL-C/HDL-C

Adjusted for age and sex

    L-spine BMD
0.080
<0.001
0.082
<0.001
0.068
<0.001

    Right neck BMD
0.100
<0.001
0.089
<0.001
0.070
<0.001

    Right total BMD
0.107
<0.001
0.087
<0.001
0.070
<0.001

    Left neck BMD
0.085
<0.001
0.089
<0.001
0.076
<0.001

    Left total BMD
0.114
<0.001
0.117
<0.001
0.086
<0.001

Adjusted for BMI

    L-spine BMD
0.038
0.033
0.026
0.137
0.022
0.219

    Right neck BMD
0.057
0.001
0.030
0.083
0.027
0.123

    Right total BMD
0.061
0.001
0.036
0.040
0.023
0.203

    Left neck BMD
0.042
0.018
0.029
0.103
0.030
0.088

    Left total BMD
0.063
0.001
0.049
0.007
0.032
0.079

Adjusted for age, sex, SBP, glucose, Cre, Hb, smoking, exercise, and vegetarian

    L-spine BMD
0.071
<0.001
0.070
<0.001
0.058
0.001

    Right neck BMD
0.092
<0.001
0.077
<0.001
0.059
0.002

    Right total BMD
0.088
<0.001
0.073
<0.001
0.047
0.012

    Left neck BMD
0.076
<0.001
0.074
<0.001
0.062
0.001

    Left total BMD
0.095
<0.001
0.095
<0.001
0.067
<0.001

Values in bold represent significant values (), and values in italic represent negative correlation. BMI: body mass index; SBP: systolic blood pressure; Cre: creatinine; Hb: hemoglobin; TG: triglyceride; TCH: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol.

3.5. Subgroup Characteristics

Of the 3249 subjects, 1998 were nonobese (women 656 and men 1342) and 1251 were obese (women 273 and men 978). Multiple regression analysis at sites of BMD and AI of TG/HDL-C ratio in subgroups dividing by sex and obesity after adjustment of age, SBP, glucose, Cre, Hb, smoking, habits of exercise, and vegetarian diet showed major significant positive correlations in all regions at male nonobese subgroup, in bilateral femoral neck and total hip regions at female nonobese subgroup, and in bilateral total hip regions of obese females (Table 5).

Table 5: Multiple linear regression for the data analysis: correlation between parameters of bone mineral density and atherogenic index of TG/HDL-C in subgroups dividing by sex (female/male) and obesity (nonobese/obese) with multiple regression analysis after adjustment of age, SBP, glucose, Cre, Hb, smoking, exercise, and vegetarian.

Adjusted for age, SBP, glucose, Cre, Hb, smoking, exercise, and vegetarian
Female nonobese (656)
Female obese (273)
Male nonobese (1342)
Male obese (978)

L-spine BMD
0.076
0.076
0.029
0.663
0.061
0.024
0.004
0.907

Right neck BMD
0.134
0.002
0.113
0.087
0.060
0.032
-0.012
0.718

Right total BMD
0.089
0.023
0.166
0.006
0.070
0.010
-0.049
0.125

Left neck BMD
0.108
0.011
0.112
0.087
0.058
0.039
-0.050
0.134

Left total BMD
0.104
0.008
0.178
0.003
0.065
0.016
-0.049
0.118

Values in bold represent significant values (), and values in italic represent negative correlation. SBP: systolic blood pressure; Cre: creatinine; Hb: hemoglobin.

4. Discussion

Lipid abnormalities, such as elevated TCH and LDL-C levels or low HDL-C level, are related to atherosclerosis [5], and TCH/HDL-C and LDL-C/HDL-C ratios have been shown to be good predictors of CAD than lipid alone [1, 4, 6]. High TG-low HDL-C dyslipidemia, which is the consequence of abdominal obesity and insulin resistance, is commonly associated with an increased concentration of small, dense LDL particles, which are atherogenic [1]. Although some lipid variables are associated with CAD extent, the TG/HDL-C ratio showed the strongest association with CAD extent [5]. Moreover, a previous study of Chinese patients with type II diabetes with stable CAD demonstrated that elevated TG/HDL-C ratio could also be a useful predictor of future cardiovascular events [25].

Yamaguchi et al. and Poli et al. found an inverse association between BMD and serum LDL-C levels in postmenopausal women, but somewhat different in the BMD measured sites [18, 19]. However, Adami et al. reported a significant positive association of serum LDL-C levels with BMD in elderly female subjects [20]. Inconsistent findings of the relationship of TCH level with BMD were also reported; moreover, some studies showed no significant correlation [21, 22]. In a South Korean population-based study of subjects aged 19–80 years, TCH and LDL-C levels were inversely associated with BMD in both premenopausal () and postmenopausal () women [23]. In a 2018 meta-analysis of postmenopausal women, TCH and LDL-C levels were higher in the osteoporosis group than in the normal bone density group [26]. In our study, we showed inverse relationships of TCH level with BMD at some sites (L-spine, right femoral neck, and bilateral total hips); however, no relationship between LDL-C level and BMD was observed.

In a prospective cohort of adults with type 1 diabetes and low-to-normal TG levels, TG at baseline independently predicted CAC progression over 6 years [27]. A previous study also showed that TG levels have a significant positive correlation with BMD values at the trochanter site among postmenopausal Korean women and a negative correlation with lumbar BMD values in the premenopausal Korean women [23]. A study in Saudi Arabia showed that glucose and TG are positively associated with total hip BMD [24], which is consistent with the findings of a related study in Italy [20]. In our study, which involved Taiwanese adults, TG levels were shown to have a consistent significant positive correlation with BMD values at all the measured sites.

Furthermore, our study showed an inverse relationship between HDL-C level and BMD values at all the sites. In contrast, previous studies showed no [18], positive [19], or negative [15, 17] relationship in postmenopausal women. Moreover, a negative relationship was noted in healthy women and men after adjusting for weight, height, and fat mass in an Italian study [20]. HDL-C levels were not associated with BMD values at any of the sites in pre- and postmenopausal subjects in a study in Korea [23]. These differences could be attributed to different study populations, age distribution, race, statistical methods, and/or adjustments.

Alissa et al. reported that TCH/HDL-C ratio was positively correlated with both femoral neck BMD and total hip BMD in 180 postmenopausal women recruited from a catheterization laboratory [24]. Adami et al. also reported that LDL-C/HDL-C ratio in women showed significantly positive relationship with BMD values after adjusting for body weight, height, and fat mass [20]. A significant negative relationship was found between whole-body bone mineral content and HDL-C/LDL-C ratio in Chinese men and women [28]. In our study, we expanded the sample size to 3249 Taiwanese adults undergoing health exam, and BMD values at all the measured sites showed significant positive associations with all three AIs (TG/HDL-C, TCH/HDL-C, and LDL-C/HDL-C ratios) in nonadjusted and some adjusted conditions.

Log(TG/HDL-C) is a strong marker for the prediction of the risk of atherosclerosis, CAD, and CVD [7]; reflects the true relationship between protective and atherogenic lipoprotein; and is associated with the size of a pre- and antiatherogenic lipoprotein particles [29]. And it is significantly positively correlated with BMI [7], so as our AI markers by naive linear regression without log. Similar to another study of HDL-C and BMD [15], the significant correlation of the novel AI, i.e., TG/HDL-C, with BMD disappeared when the correlative variables of sex and BMI were introduced. Hence, we divided our population into subgroups according to sex and BMI (obesity or nonobesity). After adjusting for age, SBP, glucose level, Cre level, Hb level, smoking, exercise, and vegetarian state, BMD at nonobese adults, except lumbar spines of nonobese women, still showed a significant positive relationship with TG/HDL-C ratio and can predict it. This is the most concrete evidence to support the purpose of our study. Moreover, total hip BMD values also could predict TG/HDL-C in the female obese subgroups. The lack of significance of lumbar spine BMD of nonobese women could be explained by the difficulty in lumbar spine BMD measurement in elderly subjects and the possibility of obtaining higher values owing to degenerative changes, such as aortic calcifications or osteophytes, which could in turn result in a “no association” finding [23]. To determine the true current status and a possible altered physiological condition after treatment, models were adjusted for clinical laboratory data instead of comorbidities.

Factors influencing BMD include age, sex, BMI, smoking, race, glucocorticoids, hyperlipidemia, and diabetes [30, 31]. A strong positive correlation between Cre clearance or Cre and bone mass or BMD values exists [32]. Our study also showed significant linear associations between Cre and TG levels and between Cre and AIs and an inverse correlation between Cre and HDL-C levels. A previous study found partial positive associations between Hb level and BMD in men but negative associations in women [33], whereas another study showed no relationship [34]. Interestingly, our data showed a significant positive association of Hb level with lipid profile, except HDL-C level, which showed a significant negative relationship, and AIs. Despite inconsistent results in the literature on smoking and BMD [35], they often showed inverse relationship [36]. Our opposite result (positive relationship) is probably due to the small percentage of smoking and older age of the nonsmoking population ( vs. years, ). Significant high atherogenic indices and proatherogenic lipids (TG, TCH, LDL-C, very LDL-C, and non-HDL-C) were observed in smokers compared to controls [37, 38]. Exercise benefits BMD in premenopausal women [39] and maintains BMD in postmenopausal women [40]. Regular exercise improves HDL-C and decreases TG, TCH, LDL-C, and VLDL [41]. Physical exercise improves not only lipid profile but also AIs [42, 43]. Long-term practitioners of vegan vegetarian were found to being classified as having osteopenia of the femoral neck [44]. Another study showed that the proportion of subjects with osteopenia or osteoporosis also appeared comparable between vegetarians and nonvegetarians of both sex [45]. Vegetarian diets effectively lower blood concentrations of TCH, LDL-C, HDL-C, and non-HDL-C, but vegetarian diets did not significantly affect blood TG concentrations [46]. After adjustment for age, sex, SBP, glucose level, Cre level, Hb level, smoking, exercise, and vegetarian state, BMD values at all the measured sites showed a significant positive correlation with the three AIs.

Bone turnover is not simply regulated by osteoblasts and osteoclasts that produce and resorb bone, respectively. Bone formation involves other more complex elements at the molecular level. Atherosclerosis and vascular calcification are complicated dynamic processes related to the regulation of oxidized lipids, leptin, bone matrix proteins (osteopontin, osteocalcin, and bone morphogenetic protein), calcification inhibitors (osteoprotegerin, matrix Gla protein, and fetuin-A), osteogene expression, and inflammatory cytokines (TNF-α, CRP, and CD40-CD154) [11, 13, 47–50]. Moreover, exogenous lipids have been implicated in the regulation of osteoblastic differentiation [51, 52], and the products of cholesterol biosynthetic pathway are important for the proper development of marrow stromal cells. Studies have found that hypercholesterolemia and the resulting deposition and oxidation of lipids in tissues result in atherosclerosis [53] and are related to osteoporotic bone loss [54]. Thus, atherosclerosis is related not only to lipids but also to bone biosynthetic factors.

The conflicting findings between our study and those in some previous studies on the association of low BMD with cardiovascular risk or events [24, 55, 56] could be due to the difference in the interaction of calcified and noncalcified atherosclerosis with lipid pathway and could be because our study sample was composed of mostly normal and asymptomatic adults undergoing a health examination. Trabecular bone score value positively predicted moderate CAC but showed no association with the high CAC group in a previous study [13]. Non-HDL-C, which is a marker of subclinical atherosclerosis, was more strongly associated with CAC than with all other conventional lipid values [57]. Noninvasive methods could determine the presence and extent of CAD, especially by CAC, HDL-C, and TG/HDL-C ratio assays [58]. The use of BMD as a predictor of AIs of CVD is a novel concept.

However, this is a retrospective study and has some limitation. First, we had no information of body fat percent or fat mass, which may be confounding factors on the association between the BMD and AIs. Second, we did not have the medication data either. Lipid-lowering medications, such as statins and fibrates, have some effects on lipid profiles. Especially, statins are thought to have significant effects on both lipid profiles and BMD. However, since the percentage of hyperlipidemia is 6.9% and the population size is 3249 subjects, the possible interference to our result could be eliminated.

5. Conclusions

AIs are significant predictors of CVD, and BMD values are predictors of AIs. Observation showed significant positive relationships of BMD with the three AIs and especially with the AI of TG/HDL-C in nonobese men (at all the sites), nonobese women (at the femoral neck and total hip), and obese women (at the total hip) after dividing the study subjects into subgroups and after further adjustments to eliminate the effect of BMI as a confounding factor. Thus, BMD values could predict the AIs of CVD, especially in nonobese adults.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

Tzyy-Ling Chuang, Jiunn-Wen Lin, and Yuh-Feng Wang declare that they have no conflict of interest regarding the publication of this article.

References

I. Lemieux, B. Lamarche, C. Couillard et al., “Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec cardiovascular study,” Archives of Internal Medicine, vol. 161, no. 22, pp. 2685–2692, 2001.

W. P. Castelli, R. J. Garrison, P. W. Wilson, R. D. Abbott, S. Kalousdian, and W. B. Kannel, “Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham study,” JAMA, vol. 256, no. 20, pp. 2835–2838, 1986.

T. Gordon, W. P. Castelli, M. C. Hjortland, W. B. Kannel, and T. R. Dawber, “High density lipoprotein as a protective factor against coronary heart disease. The Framingham study,” The American Journal of Medicine, vol. 62, no. 5, pp. 707–714, 1977.

W. P. Castelli, K. Anderson, P. W. F. Wilson, and D. Levy, “Lipids and risk of coronary heart disease The Framingham study,” Annals of Epidemiology, vol. 2, no. 1-2, pp. 23–28, 1992.

P. L. da Luz, D. Favarato, J. R. Faria-Neto Junior, P. Lemos, and A. C. P. Chagas, “High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease,” Clinics, vol. 63, no. 4, pp. 427–432, 2008.

M. K. Hong, P. A. Romm, K. Reagan, C. E. Green, and C. E. Rackley, “Usefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in women,” The American Journal of Cardiology, vol. 68, no. 17, pp. 1646–1650, 1991.

S. Niroumand, M. Khajedaluee, M. Khadem-Rezaiyan et al., “Atherogenic index of plasma (AIP): a marker of cardiovascular disease,” Medical Journal of the Islamic Republic of Iran, vol. 29, p. 240, 2015.

T. T. Wu, Y. Gao, Y. Y. Zheng, Y. T. Ma, and X. Xie, “Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women,” Lipids in Health and Disease, vol. 17, no. 1, p. 197, 2018.

C. S. Weiler Miralles, L. M. Wollinger, D. Marin, J. P. Genro, V. Contini, and S. Morelo Dal Bosco, “Waist-to-height ratio (WHtR) and triglyceride to HDL-C ratio (TG/HDL-c) as predictors of cardiometabolic risk,” Nutrición Hospitalaria, vol. 31, no. 5, pp. 2115–2121, 2015.

D. P. Kiel, L. I. Kauppila, L. A. Cupples, M. T. Hannan, C. J. O'Donnell, and P. W. F. Wilson, “Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham heart study,” Calcified Tissue International, vol. 68, no. 5, pp. 271–276, 2001.

C. M. Giachelli, L. Liaw, C. E. Murry, S. M. Schwartz, and M. Almeida, “Osteopontin expression in cardiovascular diseases,” Annals of the New York Academy of Sciences, vol. 760, 1 Osteopontin, pp. 109–126, 1995.

L. B. Tanko, Y. Z. Bagger, and C. Christiansen, “Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women,” Calcified Tissue International, vol. 73, no. 1, pp. 15–20, 2003.

T. L. Chuang, F. T. Hsiao, Y. D. Li, and Y. F. Wang, “TBS predict coronary artery calcification in adults,” BioMed Research International, vol. 2016, Article ID 8391589, 6 pages, 2016.

T.-L. Chuang, F.-T. Hsiao, Y.-D. Li, and Y.-F. Wang, “Bone mineral density in evaluation of the severity of coronary artery calcification,” Annals of Nuclear Medicine and Molecular Imaging, vol. 30, no. 2, pp. 55–61, 2017.

P. D'Amelio, S. Di Bella, C. Tamone et al., “HDL cholesterol and bone mineral density in normal-weight postmenopausal women: is there any possible association?” Panminerva Medica, vol. 50, no. 2, pp. 89–96, 2008.

F. Orio, S. Palomba, T. Cascella, S. Savastano, G. Lombardi, and A. Colao, “Cardiovascular complications of obesity in adolescents,” Journal of Endocrinological Investigation, vol. 30, no. 1, pp. 70–80, 2007.

P. D’Amelio, G. P. Pescarmona, A. Gariboldi, and G. C. Isaia, “High density lipoproteins (HDL) in women with postmenopausal osteoporosis: a preliminary study,” Menopause, vol. 8, no. 6, pp. 429–432, 2001.

A. Poli, F. Bruschi, B. Cesana, M. Rossi, R. Paoletti, and P. G. Crosignani, “Plasma low-density lipoprotein cholesterol and bone mass densitometry in postmenopausal women,” Obstetrics and Gynecology, vol. 102, Part 1, no. 5, pp. 922–926, 2003.

T. Yamaguchi, T. Sugimoto, S. Yano et al., “Plasma lipids and osteoporosis in postmenopausal women,” Endocrine Journal, vol. 49, no. 2, pp. 211–217, 2002.

S. Adami, V. Braga, M. Zamboni et al., “Relationship between lipids and bone mass in 2 cohorts of healthy women and men,” Calcified Tissue International, vol. 74, no. 2, pp. 136–142, 2004.

E. J. Samelson, L. A. Cupples, M. T. Hannan et al., “Long-term effects of serum cholesterol on bone mineral density in women and men: the Framingham osteoporosis study,” Bone, vol. 34, no. 3, pp. 557–561, 2004.

L.‐. Y. Wu, T.‐. C. Yang, S.‐. W. Kuo et al., “Correlation between bone mineral density and plasma lipids in Taiwan,” Endocrine Research, vol. 29, no. 3, pp. 317–325, 2003.

L. H. Cui, M. H. Shin, E. K. Chung et al., “Association between bone mineral densities and serum lipid profiles of pre- and post-menopausal rural women in South Korea,” Osteoporosis International, vol. 16, no. 12, pp. 1975–1981, 2005.

E. M. Alissa, W. A. Alnahdi, N. Alama, and G. A. Ferns, “Bone mineral density and cardiovascular risk factors in postmenopausal women with coronary artery disease,” BoneKEy Reports, vol. 4, p. 758, 2015.

S. H. Yang, Y. du, X. L. Li et al., “Triglyceride to high-density lipoprotein cholesterol ratio and cardiovascular events in diabetics with coronary artery disease,” The American Journal of the Medical Sciences, vol. 354, no. 2, pp. 117–124, 2017.

Y. Y. Chen, W. W. Wang, L. Yang, W. W. Chen, and H. X. Zhang, “Association between lipid profiles and osteoporosis in postmenopausal women: a meta-analysis,” European Review for Medical and Pharmacological Sciences, vol. 22, no. 1, pp. 1–9, 2018.

P. Bjornstad, D. M. Maahs, R. P. Wadwa et al., “Plasma triglycerides predict incident albuminuria and progression of coronary artery calcification in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes study,” Journal of Clinical Lipidology, vol. 8, no. 6, pp. 576–583, 2014.

Y. H. Hsu, S. A. Venners, H. A. Terwedow et al., “Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women,” The American Journal of Clinical Nutrition, vol. 83, no. 1, pp. 146–154, 2006.

M. Dobiasova, J. Frohlich, M. Sedova, M. C. Cheung, and B. G. Brown, “Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography,” Journal of Lipid Research, vol. 52, no. 3, pp. 566–571, 2011.

M. Walker, A. C. Janot, M. Yu, H. K. Grewal, M. R. Lammi, and L. A. Saketkoo, “Assessment of protective factors of bone mineral density in a New Orleans sarcoidosis population,” American Journal of Respiratory and Critical Care Medicine, vol. 191, article A3759, 2015.

H.-S. Lee, “The factors influencing the bone mineral density in Korean adult men: based on Korea national health and nutrition examination survey 2010~2011 data,” Korean Journal of Community Nutrition, vol. 22, no. 2, pp. 136–144, 2017.

J. H. Huh, S. I. Choi, J. S. Lim, C. H. Chung, J. Y. Shin, and M. Y. Lee, “Lower serum creatinine is associated with low bone mineral density in subjects without overt nephropathy,” PLoS One, vol. 10, no. 7, article e0133062, 2015.

Y. H. Oh, J. H. Moon, and B. Cho, “Association between hemoglobin level and bone mineral density in Korean adults,” Journal of Bone Metabolism, vol. 24, no. 3, pp. 161–173, 2017.

R. J. Valderrábano, P. Buzkova, P. Y. Chang et al., “Association of bone mineral density with hemoglobin and change in hemoglobin among older men and women: the cardiovascular health study,” Bone, vol. 120, pp. 321–326, 2019.

D. Strozyk, T. M. Gress, and L. P. Breitling, “Smoking and bone mineral density: comprehensive analyses of the third National Health and Nutrition Examination Survey (NHANES III),” Archives of Osteoporosis, vol. 13, no. 1, p. 16, 2018.

R. Ghadimi, S. R. Hosseini, S. Asefi, A. Bijani, B. Heidari, and M. Babaei, “Influence of smoking on bone mineral density in elderly men,” International Journal of Preventive Medicine, vol. 9, no. 1, p. 111, 2018.

N. S. Neki, “Lipid profile in chronic smokers – a clinical study,” JIACM, vol. 3, no. 1, pp. 51–54, 2002.

A. Agbecha and A. E. Ameh, “Atherogenic indices and smoking habits in cigarette smokers,” Environmental Disease, vol. 3, no. 2, p. 38, 2018.

G. A. Kelley, K. S. Kelley, and W. M. Kohrt, “Exercise and bone mineral density in premenopausal women: a meta-analysis of randomized controlled trials,” International Journal of Endocrinology, vol. 2013, Article ID 741639, 16 pages, 2013.

N. A. de Almeida Carvalho, S. Bittar, B. E. Matsuda Marangoni, and C. Santili, “The impact of exercising on bone mineral density in women exercising on bone mineral density,” Journal of Exercise, Sports & Orthopedics, vol. 1, pp. 1–7, 2014.

J. C. Oranwa, I. S. Ogbu, J. E. Ikekpeazu, K. C. Onyekwelu, E. A. Esom, and M. C. Ugonabo, “Lipid profile of people engaged in regular exercise,” Annals of Medical and Health Sciences Research, vol. 7, pp. 36–39, 2017.

Z. Stranska, M. Matoulek, Z. Vilikus, S. Svacina, and P. Stransky, “Aerobic exercise has beneficial impact on atherogenic index of plasma in sedentary overweigh and obese women,” Neuro Endocrinology Letters, vol. 32, no. 1, pp. 102–108, 2011.

S. Shen, Y. Lu, Y. Dang et al., “Effect of aerobic exercise on the atherogenic index of plasma in middle-aged Chinese men with various body weights,” International Journal of Cardiology, vol. 230, pp. 1–5, 2017.

J. F. Chiu, S. J. Lan, C. Y. Yang et al., “Long-term vegetarian diet and bone mineral density in postmenopausal Taiwanese women,” Calcified Tissue International, vol. 60, no. 3, pp. 245–249, 1997.

Y. F. Wang, J. S. Chiu, M. H. Chuang, J. E. Chiu, and C. L. Lin, “Bone mineral density of vegetarian and non-vegetarian adults in Taiwan,” Asia Pacific Journal of Clinical Nutrition, vol. 17, no. 1, pp. 101–106, 2008.

F. Wang, J. Zheng, B. Yang, J. Jiang, Y. Fu, and D. Li, “Effects of vegetarian diets on blood lipids: a systematic review and meta-analysis of randomized controlled trials,” Journal of the American Heart Association, vol. 4, no. 10, article e002408, 2015.

P. Lanzer, M. Boehm, V. Sorribas et al., “Medial vascular calcification revisited: review and perspectives,” European Heart Journal, vol. 35, no. 23, pp. 1515–1525, 2014.

K. Amann, “Media calcification and intima calcification are distinct entities in chronic kidney disease,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 6, pp. 1599–1605, 2008.

J. C. Fleet and J. M. Hock, “Identification of osteocalcin mRNA in nonosteoid tissue of rats and humans by reverse transcription-polymerase chain reaction,” Journal of Bone and Mineral Research, vol. 9, no. 10, pp. 1565–1573, 1994.

Y. Tintut and L. L. Demer, “Recent advances in multifactorial regulation of vascular calcification,” Current Opinion in Lipidology, vol. 12, no. 5, pp. 555–560, 2001.

M. C. Kruger and D. F. Horrobin, “Calcium metabolism, osteoporsis and essential fatty acids: a review,” Progress in Lipid Research, vol. 36, no. 2-3, pp. 131–151, 1997.

B. A. Watkins, C. L. Shen, J. P. McMurtry et al., “Dietary lipids modulate bone prostaglandin E₂ production, insulin-like growth factor-I concentration and formation rate in chicks,” The Journal of Nutrition, vol. 127, no. 6, pp. 1084–1091, 1997.

R. Ross, “Atherosclerosis--an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999.

F. Parhami, A. Garfinkel, and L. L. Demer, “Role of lipids in osteoporosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 11, pp. 2346–2348, 2000.

L. B. Tanko, C. Christiansen, D. A. Cox, M. J. Geiger, M. A. McNabb, and S. R. Cummings, “Relationship between osteoporosis and cardiovascular disease in postmenopausal women,” Journal of Bone and Mineral Research, vol. 20, no. 11, pp. 1912–1920, 2005.

E. J. Samelson, D. P. Kiel, K. E. Broe et al., “Metacarpal cortical area and risk of coronary heart disease: the Framingham study,” American Journal of Epidemiology, vol. 159, no. 6, pp. 589–595, 2004.

S. H. Orakzai, K. Nasir, M. Blaha, R. S. Blumenthal, and P. Raggi, “Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals,” Atherosclerosis, vol. 202, no. 1, pp. 289–295, 2009.

A. B. A. Bampi, C. E. Rochitte, D. Favarato, P. A. Lemos, and P. L. da Luz, “Comparison of non-invasive methods for the detection of coronary atherosclerosis,” Clinics, vol. 64, no. 7, pp. 675–682, 2009.